ARTEVU: ArteVu Blood Pressure Accuracy Study

Sponsor
Cardio Ring Technologies, Inc. Taiwan Branch (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05105204
Collaborator
Taipei Medical University Hospital (Other)
50
1
8.5
5.9

Study Details

Study Description

Brief Summary

A continuous noninvasive blood pressure monitoring digital fingertip clip device, the ArteVu, will be compared against the reference arterial catheter during operation. The device safety and its blood pressure accuracy will be examined in the study.

Condition or Disease Intervention/Treatment Phase
  • Device: ArteVu

Detailed Description

ArteVu is a non-invasive and continuous blood pressure monitor. It detects the arterial pressure waveform with a force sensor that detects the arterial pulsation that produces changes in pressure transmitted through the subcutaneous tissue overlying or adjacent to the digital arteries. The data is transmitted to a parameter module to display noninvasive and continuous blood pressure in a hospital setting. The primary objective of this study is to validate ArteVu's blood pressure and heart rate measurement accuracy by comparing its values simultaneously with the corresponding values obtained from an invasive radial arterial line. The secondary objective is to evaluate the effectiveness of utilizing ArteVu for continuous blood pressure measurements. The study population includes 50 patients undergoing surgery who requires general anesthesia and continuous blood pressure measurement with a radial arterial line. Blood pressure values measured from the arterial line will be recorded simultaneously during ArteVu's measurements.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
50 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
ArteVu Blood Pressure Accuracy Study
Actual Study Start Date :
Sep 14, 2021
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Individuals need intra-arterial catheter at the radial artery for blood pressure monitoring

Individuals who requiring the use of intra-arterial catheter at the radial artery for continuous blood pressure monitoring for at least two hours as part of their planned care.

Device: ArteVu
The study participants will concurrently undergo noninvasive blood pressure monitoring with the ArteVu finger clip applied to the same extremity that is being used to measure the radial artery pressure.

Outcome Measures

Primary Outcome Measures

  1. Blood pressure and heart rate measurement accuracy [around two hours.]

    To validate ArteVu's blood pressure and heart rate measurement accuracy by comparing its values simultaneously with the corresponding values obtained intra-arterially from an invasive radial arterial line, meeting a bias (as measured by overall mean difference) less than 5 mmHg and a standard deviation less than 8 mmHg for systolic and diastolic blood pressure. This accuracy satisfies the limits established for the validation of automatic blood pressure measurement according to the ANSI/AAMI/ISO 81060-2 standard.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age ≥ 20 years

  2. Requiring general anesthesia and continuous blood pressure measurement with a radial arterial line

  3. Limb circumference is within 22 cm - 32 cm

  4. The width of the first knuckle of the index/middle/Ring finger is less than 19.8 mm

  5. Ease of access to the finger and arm used for ArteVu

  6. Able to provide written informed consent for participation in the study

Exclusion Criteria:
  1. Pregnant patients

  2. Medical or surgical condition that prevents the ability to apply the ArteVu device on an upper extremity finger or the ipsilateral arm such as impaired skin integrity

  3. Operations involving the upper extremities or the blood vessels of the upper extremities

  4. Arthritis or severe deformities of the hand and fingers

  5. Prosthetic devices or jewelry that cannot be removed from the finger or the ipsilateral arm to be used for the ArteVu device

  6. History of malignant hyperthermia

  7. Raynaud's disease affecting the fingers or hands

  8. Topical allergy to Acrylonitrile Butadiene Styrene(ABS), Polycarbonate(PC), or silicone

  9. Swelling, edema or lymphedema of the upper extremity

  10. Participants with upper extremity occlusive peripheral vascular diseases

  11. Inability of the patient to provide written informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taipei Medical University Hospital Taipei City Taiwan 11031

Sponsors and Collaborators

  • Cardio Ring Technologies, Inc. Taiwan Branch
  • Taipei Medical University Hospital

Investigators

  • Principal Investigator: Chuen-Chau Chang, M.D,PhD., Taipei Medical University Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Cardio Ring Technologies, Inc. Taiwan Branch
ClinicalTrials.gov Identifier:
NCT05105204
Other Study ID Numbers:
  • N202106030
First Posted:
Nov 3, 2021
Last Update Posted:
Nov 3, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Cardio Ring Technologies, Inc. Taiwan Branch

Study Results

No Results Posted as of Nov 3, 2021